Vol 4 (September 30, 2021): Precision Cancer Medicine

Case Report 
Massive hyper-progression during anti-PD-1 immunotherapy in a young patient with metastatic mucinous adenocarcinoma of the right colon: a case report and literature review
Chiara Guarini, Annalisa Todisco, Marco Tucci, Camillo Porta, Francesco Mannavola
Precision Cancer Medicine  
2021;
4:
30  
Review Article 
Women treating lung cancer: a narrative review
Maria Teresa R. Tsukazan, Ana Gelatti, Paula A. Ugalde
Precision Cancer Medicine  
2021;
4:
29  
Review Article 
Next-generation sequencing using liquid biopsy in the care of patients with ALK-rearranged non-small cell lung cancer: a focus on lorlatinib
Juan B. Blaquier, Andrés F. Cardona, Alessandro Russo, Christian Rolfo, Gonzalo Recondo
Precision Cancer Medicine  
2021;
4:
28  
Review Article 
Asbestos-induced chronic inflammation in malignant pleural mesothelioma and related therapeutic approaches—a narrative review
Alicia A. Zolondick, Giovanni Gaudino, Jiaming Xue, Harvey I. Pass, Michele Carbone, Haining Yang
Precision Cancer Medicine  
2021;
4:
27  
Review Article 
Sex-based heterogeneity in non-small cell lung cancer (NSCLC) and response to immune checkpoint inhibitors (ICIs): a narrative review
Stefano Frega, Alessandra Ferro, Laura Bonanno, Valentina Guarneri, PierFranco Conte, Giulia Pasello
Precision Cancer Medicine  
2021;
4:
26  
Review Article 
ROS1 non-small cell lung cancer patients treatment approach
Laura Moliner, Edurne Arriola
Precision Cancer Medicine  
2021;
4:
25  
Review Article 
A narrative review of biomarkers in advanced triple negative breast cancer
Rania Chehade, Arif A. Awan, Ricardo Fernandes
Precision Cancer Medicine  
2021;
4:
24  
Review Article 
A narrative review of predictive and prognostic biomarkers in skin tumors
Anna M. Stagner, Rosalynn M. Nazarian
Precision Cancer Medicine  
2021;
4:
22